Cargando…
Peptide Dose and/or Structure in Vaccines as a Determinant of T Cell Responses
While T cells recognise the complex of peptide and major histocompatibility complex (MHC) at the cell surface, changes in the dose and/or structure of the peptide component can have profound effects on T cell activation and function. In addition, the repertoire of T cells capable of responding to an...
Autor principal: | Leggatt, Graham R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494221/ https://www.ncbi.nlm.nih.gov/pubmed/26344744 http://dx.doi.org/10.3390/vaccines2030537 |
Ejemplares similares
-
PD-1 and beyond to Activate T Cells in Cutaneous Squamous Cell Cancers: The Case for 4-1BB and VISTA Antibodies in Combination Therapy
por: Wright, Quentin, et al.
Publicado: (2021) -
NKT cell-targeted vaccination plus anti-4–1BB antibody generates persistent CD8 T cell immunity against B cell lymphoma
por: Kobayashi, Takumi, et al.
Publicado: (2015) -
Investigating T Cell Immunity in Cancer: Achievements and Prospects
por: Zeng, Zhen, et al.
Publicado: (2021) -
Evolution of Cancer Vaccines—Challenges, Achievements, and Future Directions
por: Tay, Ban Qi, et al.
Publicado: (2021) -
Impact of Sex Steroid Ablation on Viral, Tumour and Vaccine Responses in Aged Mice
por: Heng, Tracy S. P., et al.
Publicado: (2012)